Australia's Sirtex picks $1.4 billion Chinese bid over Varian offer: Reuters

Australia’s Sirtex Medical (SRX.AX) has picked the highest bidder in a takeover battle for the liver cancer specialist, going with a $1.4 billion Chinese offer that trumped U.S. company Varian Medical Systems (VAR.N), Reuters reported.